Effectiveness of three types of rapid tests for the detection of hepatitis C virus antibodies among blood donors in Alexandria, Egypt

Journal of Virological Methods

Volumn 189, Issue 2, 2013, Pages 370-374

  Al Tahish, Ghamdan ^a,b   El Barrawy, Mohamed A ^b   Hashish, Mona H ^b   Heddaya, Zeinab ^c  

^a HODEIDAH UNIVERSITY   (Yemen)

^b High Institute of Public Health Egypt   (Egypt)

^c Ministry of Health and Population   (Egypt)

Author keywords

ELISA; Flow through test; Hepatitis C virus; Immunochromatographic HCV test; PCR; Rapid test

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C RAPID TEST; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BLOOD DONORS; DIAGNOSTIC TESTS, ROUTINE; EGYPT; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 84876723671     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.03.013     Document Type: Article

References (33)

1. Benouda A., Boujdiya Z., Ahid S., Abouqal R.M.A. Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. Pathol. Biol. 2009, 57:368-372.
2. Carneiro M.A., Martins R.M., Teles S.A., Silva S.A., Lopes C.L., Cardoso D.D., et al. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem. Inst. Oswaldo Cruz 2001, 96:765-769.
3. Colin C., Lanoir D., Touzet S., Meyaud-Kraemer L., Bailly F., Trepo C. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J. Viral Hepat. 2001, 8:87-95.
4. Daniel H.D., Abraham P., Raghuraman S., Vivekanandan P., Subramaniam T., Sridharan G. Evaluation of a rapid assay as an alternative to conventional enzyme immunoassays for detection of hepatitis C virus-specific antibodies. J. Clin. Microbiol. 2005, 43:1977-1978.
5. Desbois D., Vaghefi P., Savary J., Dussaix E., Roque-Afonso A.M. Sensitivity of a rapid immuno-chromatographic test for hepatitis C antibodies detection. J. Clin. Virol. 2008, 41:129-133.
6. Diaz S., Liu P., Kuhnert W.L., Healy M., Prince A.M., El-Nageh M.M. Development of the International Consortium for Blood Safety (ICBS) HCV panels. East. Mediterr. Health J. 2008, 14:427-437.
7. Erensoy S. Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. J. Clin. Virol. 2001, 21:271-281.
8. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355:887-891.
9. Gao G., Buskell Z., Seeff L., Tabor E. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J. Med. Virol. 2002, 68:60-67.
10. ICBS Blood Screening Test Evaluation Center at PEI, 2006. Evaluation results of some commercially available anti-HCV test kits used in countries with limited resources. Available from: http://www.icbs-web.org/ICBS-PEI-table3.pdf.
11. Ishii S., Koziel M.J. Immune responses during acute and chronic infection with hepatitis C virus. Clin. Immunol. 2008, 128:133-147.
12. Jourbert J.J., Dewar J.B., Weinberg J., De Beer M., Parker J.S., Steele A.D. A cost-effective particle agglutination assay to detect viral antibodies in dried blood spots-a simple solution to HIV and HCV screening. Cent. Afr. J. Med. 2003, 49:127-130.
13. Kapoor, D., Saxena, R., Sood, B., Sarin, S.K., 2000. Blood transfusion practices in India: results of a national survey. Indian J. Gastroenterol. 19, 64-67.
14. Kaur H., Dhanao J., Oberoi A. Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. Indian J. Med. Sci. 2000, 54:432-434.
15. Lakshmi V., Reddy A.K., Dakshinamurty K.V. Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis. Indian J. Med. Microbiol. 2007, 25:140-142.
16. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
17. Lee H.H., Allain J.P. Improving blood safety in resource-poor settings. Vox. Sang. 2004, 87(Suppl. 2):176-179.
18. Mbanya D., Binam F., Kaptue L. Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation. Int. J. Infect. Dis. 2001, 5:70-73.
19. Montebugnoli L., Borea G., Miniero R., Sprovieri G. A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood. Clin. Chim. Acta 1999, 288:91-96.
20. Muktar H.M., Jones M., Ashie J. Hepatitis C virus infection in blood donors: an emerging risk to transfusion services. Ann. Afr. Med. 2006, 5:182-184.
21. Njouom R., Tejiokem M.C., Zanga M.C., Pouillot R., Ayouba A., Pasquier C., et al. A cost-effective algorithm for the diagnosis of hepatitis C virus infection and prediction of HCV viremia in Cameroon. J. Virol. Methods 2006, 133:223-226.
22. Orland J.R., Wright T.L., Cooper S. Acute hepatitis C. Hepatology 2001, 33:321-327.
23. Owusu-Ofori S., Temple J., Sarkodie F., Anokwa M., Candotti D., Allain J.P. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005, 45:133-140.
24. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium, 1999. Global surveillance and control of hepatitis C. J. Viral Hepat. 6, 35-47.
25. Richter S.S. Laboratory assays for diagnosis and management of hepatitis C virus infection. J. Clin. Microbiol. 2002, 40:4407-4412.
26. Scheiblauer H., El-Nageh M., Nick S., Fields H., Prince A., Diaz S. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 2006, 46:708-718.
27. Veillon P. Evaluation of sensitivity and specificity of a new generation of ImmunoComb II HCV for the detection of anti-hepatitis C virus antibodies. 14th European Congress of Clinical Microbiology and Infectious Diseases 2004, 1645. ESCMID, Prague, Czech Republic.
28. WHO Blood Safety and Clinical Technology, 2001a. Hepatitis C assays: operational characteristics (Phase 1), Report 1. World Health Organization, Geneva.
29. WHO Blood Safety and Clinical Technology Strategy 2000-2003, 2001b. World Health Organization, Geneva.
30. WHO Blood Safety and Clinical Technology, 2001c. Hepatitis C assays: operational characteristic (phase I), Report 2. World Health Organization, Geneva.
31. Wild C.P., Hall A.J. Primary prevention of hepatocellular carcinoma in developing countries. Mutat. Res. 2000, 462:381-393.
32. Yaari A., Tovbin D., Zlotnick M., Mostoslavsky M., Shemer-Avni Y., Hanuka N., et al. Detection of HCV salivary antibodies by a simple and rapid test. J. Virol. Methods 2006, 133:1-5.
33. Yuen M.F., Hui C.K., Yuen J.C., Young J.L., Lai C.L. The accuracy of SM-HCV rapid test for the detection of antibody to hepatitis C virus. Am. J. Gastroenterol. 2001, 96:838-841.